欧洲-话题@MedSci

#欧洲#

592篇内容 | 6064人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1339343, encodeId=ef2f133934369, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Eur Heart J ：使用80 mg辛伐他汀，肌病风险增加20倍！欧洲心脏杂志研究, objectType=article, longId=198402, objectId=2d0a19840249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0a19840249, replyNumber=0, likeNumber=76, createdTime=2020-08-01, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0a19840249, moduleTitle=Eur Heart J ：使用80 mg辛伐他汀，肌病风险增加20倍！欧洲心脏杂志研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d0a19840249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339342, encodeId=a016133934225, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Asunercept治疗COVID-19：已在欧洲及俄罗斯开展II期临床试验, objectType=article, longId=198325, objectId=726b198325ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=726b198325ff, replyNumber=0, likeNumber=59, createdTime=2020-07-31, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=726b198325ff, moduleTitle=Asunercept治疗COVID-19：已在欧洲及俄罗斯开展II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=726b198325ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339341, encodeId=32351339341e5, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Eur Heart J ：常吃蔬菜、水果和奶制品可防卒中！欧洲9国近42万人研究, objectType=article, longId=198082, objectId=e53e198082b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e53e198082b4, replyNumber=0, likeNumber=72, createdTime=2020-07-28, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e53e198082b4, moduleTitle=Eur Heart J ：常吃蔬菜、水果和奶制品可防卒中！欧洲9国近42万人研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e53e198082b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339340, encodeId=915e133934093, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲潜在的治疗软骨发育不全的药物vosoritide：正式提交营销申请, objectType=article, longId=198019, objectId=3c461980190f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c461980190f, replyNumber=0, likeNumber=69, createdTime=2020-07-26, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c461980190f, moduleTitle=欧洲潜在的治疗软骨发育不全的药物vosoritide：正式提交营销申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c461980190f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339339, encodeId=57fd133933994, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Eur Heart J：半数中风与心血管病有关，中风诊治需要心脏科医生！欧洲心脏杂志述评, objectType=article, longId=197985, objectId=31be19e9850d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31be19e9850d, replyNumber=0, likeNumber=96, createdTime=2020-07-26, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31be19e9850d, moduleTitle=Eur Heart J：半数中风与心血管病有关，中风诊治需要心脏科医生！欧洲心脏杂志述评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31be19e9850d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339338, encodeId=918f133933887, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲科研人员开发出一种新冠病毒快速检测设备, objectType=article, longId=197309, objectId=8ff619e30918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ff619e30918, replyNumber=0, likeNumber=93, createdTime=2020-07-11, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ff619e30918, moduleTitle=欧洲科研人员开发出一种新冠病毒快速检测设备, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ff619e30918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339337, encodeId=7c70133933e63, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=靶向HER2的抗体药物偶联物ENHERTU治疗乳腺癌，获得欧洲药品管理局的快速审查, objectType=article, longId=197261, objectId=e32219e26199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32219e26199, replyNumber=0, likeNumber=84, createdTime=2020-07-10, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32219e26199, moduleTitle=靶向HER2的抗体药物偶联物ENHERTU治疗乳腺癌，获得欧洲药品管理局的快速审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32219e26199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339336, encodeId=89d6133933633, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=EClinical Medicine：欧洲新冠肺炎ICU患者死亡风险因素研究, objectType=article, longId=197191, objectId=a38219e1919b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38219e1919b, replyNumber=0, likeNumber=95, createdTime=2020-07-09, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38219e1919b, moduleTitle=EClinical Medicine：欧洲新冠肺炎ICU患者死亡风险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38219e1919b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339335, encodeId=b6231339335fc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=北京新发疫情为强新冠病毒株D614G，感染力增强2.6倍，源自欧洲, objectType=article, longId=197036, objectId=ba4a19e036f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba4a19e036f6, replyNumber=0, likeNumber=71, createdTime=2020-07-06, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba4a19e036f6, moduleTitle=北京新发疫情为强新冠病毒株D614G，感染力增强2.6倍，源自欧洲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba4a19e036f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339334, encodeId=7a661339334e0, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=IDELVION获得欧洲批准，成为第一个也是**的每21天给药一次的凝血因子IX疗法, objectType=article, longId=197034, objectId=83fa19e034fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83fa19e034fd, replyNumber=0, likeNumber=79, createdTime=2020-07-05, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83fa19e034fd, moduleTitle=IDELVION获得欧洲批准，成为第一个也是**的每21天给药一次的凝血因子IX疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83fa19e034fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339333, encodeId=aed61339333b8, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=针对遗传性视网膜营养不良的基因疗法SPVN06，获得欧洲孤儿药称号, objectType=article, longId=196869, objectId=be3a196869f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be3a196869f1, replyNumber=0, likeNumber=67, createdTime=2020-07-02, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be3a196869f1, moduleTitle=针对遗传性视网膜营养不良的基因疗法SPVN06，获得欧洲孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be3a196869f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339332, encodeId=2fc013393326a, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=欧洲药品管理局的6月会议要点：建议批准八种药物, objectType=article, longId=196578, objectId=8ff41965e83e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ff41965e83e, replyNumber=0, likeNumber=70, createdTime=2020-06-28, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ff41965e83e, moduleTitle=欧洲药品管理局的6月会议要点：建议批准八种药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ff41965e83e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339331, encodeId=06d6133933194, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=PD-L1单抗Bavencio：正在欧洲接受审查以治疗转移性尿路上皮癌, objectType=article, longId=196293, objectId=15011962937c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15011962937c, replyNumber=0, likeNumber=49, createdTime=2020-06-24, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15011962937c, moduleTitle=PD-L1单抗Bavencio：正在欧洲接受审查以治疗转移性尿路上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15011962937c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339330, encodeId=1bbf13393309d, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=百济神州的BTK抑制剂Brukinsa，在欧洲接受审查用于治疗华氏巨球蛋白血症, objectType=article, longId=196197, objectId=35d019619e84, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35d019619e84, replyNumber=0, likeNumber=68, createdTime=2020-06-22, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35d019619e84, moduleTitle=百济神州的BTK抑制剂Brukinsa，在欧洲接受审查用于治疗华氏巨球蛋白血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35d019619e84)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339329, encodeId=99e31339329d3, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=心梗后舒张压<70 mmHg有危险！欧洲心脏杂志研究称：这类患者更需再灌注治疗, objectType=article, longId=195565, objectId=d0d819556534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0d819556534, replyNumber=0, likeNumber=64, createdTime=2020-06-11, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0d819556534, moduleTitle=心梗后舒张压<70 mmHg有危险！欧洲心脏杂志研究称：这类患者更需再灌注治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0d819556534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339328, encodeId=51cf13393289c, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Nature：评估非药物干预对欧洲COVID-19的影响, objectType=article, longId=195562, objectId=133819556240, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=133819556240, replyNumber=0, likeNumber=68, createdTime=2020-06-11, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=133819556240, moduleTitle=Nature：评估非药物干预对欧洲COVID-19的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=133819556240)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339327, encodeId=fb6f133932ec8, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=所有心血管病人都该看牙科！欧洲牙周病学联盟与世界心脏联盟共识, objectType=article, longId=195536, objectId=188f19553691, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=188f19553691, replyNumber=0, likeNumber=83, createdTime=2020-06-11, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=188f19553691, moduleTitle=所有心血管病人都该看牙科！欧洲牙周病学联盟与世界心脏联盟共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=188f19553691)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339326, encodeId=17f3133932660, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=Allergy：患者/护理者对花生过敏治疗看法的泛欧洲调查 , objectType=article, longId=195462, objectId=6aef19546216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aef19546216, replyNumber=0, likeNumber=70, createdTime=2020-06-09, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aef19546216, moduleTitle=Allergy：患者/护理者对花生过敏治疗看法的泛欧洲调查 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aef19546216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339325, encodeId=444313393257b, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=BRAF抑制剂Braftovi获欧洲药品管理局批准，与EGFR抗体Erbitux联合治疗结直肠癌, objectType=article, longId=195394, objectId=51fd195394e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51fd195394e1, replyNumber=0, likeNumber=70, createdTime=2020-06-07, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51fd195394e1, moduleTitle=BRAF抑制剂Braftovi获欧洲药品管理局批准，与EGFR抗体Erbitux联合治疗结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51fd195394e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1339324, encodeId=64a8133932449, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, objectTitle=【实锤】《Science》研究证实：纽约市的COVID-19起源于欧洲和美国, objectType=article, longId=195362, objectId=8b26195362e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b26195362e2, replyNumber=0, likeNumber=55, createdTime=2020-06-07, rootId=0, userName=ms9474365431325850, userId=5c442500150, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b26195362e2, moduleTitle=【实锤】《Science》研究证实：纽约市的COVID-19起源于欧洲和美国, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b26195362e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

欧洲

2020-05-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Eur Heart J ：使用80 mg辛伐他汀，肌病风险增加20倍！欧洲心脏杂志研究

2020-08-01

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Asunercept治疗COVID-19：已在欧洲及俄罗斯开展II期临床试验

2020-07-31

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Eur Heart J ：常吃蔬菜、水果和奶制品可防卒中！欧洲9国近42万人研究

2020-07-28

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲潜在的治疗软骨发育不全的药物vosoritide：正式提交营销申请

2020-07-26

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Eur Heart J：半数中风与心血管病有关，中风诊治需要心脏科医生！欧洲心脏杂志述评

2020-07-26

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲科研人员开发出一种新冠病毒快速检测设备

2020-07-11

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

靶向HER2的抗体药物偶联物ENHERTU治疗乳腺癌，获得欧洲药品管理局的快速审查

2020-07-10

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

EClinical Medicine：欧洲新冠肺炎ICU患者死亡风险因素研究

2020-07-09

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

北京新发疫情为强新冠病毒株D614G，感染力增强2.6倍，源自欧洲

2020-07-06

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

IDELVION获得欧洲批准，成为第一个也是**的每21天给药一次的凝血因子IX疗法

2020-07-05

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

针对遗传性视网膜营养不良的基因疗法SPVN06，获得欧洲孤儿药称号

2020-07-02

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

欧洲药品管理局的6月会议要点：建议批准八种药物

2020-06-28

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

PD-L1单抗Bavencio：正在欧洲接受审查以治疗转移性尿路上皮癌

2020-06-24

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

百济神州的BTK抑制剂Brukinsa，在欧洲接受审查用于治疗华氏巨球蛋白血症

2020-06-22

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

心梗后舒张压<70 mmHg有危险！欧洲心脏杂志研究称：这类患者更需再灌注治疗

2020-06-11

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Nature：评估非药物干预对欧洲COVID-19的影响

2020-06-11

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

所有心血管病人都该看牙科！欧洲牙周病学联盟与世界心脏联盟共识

2020-06-11

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

Allergy：患者/护理者对花生过敏治疗看法的泛欧洲调查

2020-06-09

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

BRAF抑制剂Braftovi获欧洲药品管理局批准，与EGFR抗体Erbitux联合治疗结直肠癌

2020-06-07

ms9474365431325850 (审核中...)

前往app查看评论内容

#欧洲#

【实锤】《Science》研究证实：纽约市的COVID-19起源于欧洲和美国

2020-06-07

科室
- - 订阅+
  - 更多科室
工具
服务